Early Anuria in Incident Peritoneal Dialysis Patients: Incidence, Risk Factors, and Associated Clinical Outcomes

IF 3.2 Q1 UROLOGY & NEPHROLOGY
Shiyan Tu , Hongjian Ye , Yangyang Xin , Yuan Peng , Ruihua Liu , Jing Guo , Chunyan Yi , Haiping Mao , Xiao Yang
{"title":"Early Anuria in Incident Peritoneal Dialysis Patients: Incidence, Risk Factors, and Associated Clinical Outcomes","authors":"Shiyan Tu ,&nbsp;Hongjian Ye ,&nbsp;Yangyang Xin ,&nbsp;Yuan Peng ,&nbsp;Ruihua Liu ,&nbsp;Jing Guo ,&nbsp;Chunyan Yi ,&nbsp;Haiping Mao ,&nbsp;Xiao Yang","doi":"10.1016/j.xkme.2024.100882","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale &amp; Objective</h3><p>The development of anuria has been linked to worse clinical outcomes in patients undergoing peritoneal dialysis (PD). Our objective was to investigate the incidence, risk factors, and associated clinical outcomes of anuria within the first year after starting PD.</p></div><div><h3>Study Design</h3><p>Retrospective cohort study.</p></div><div><h3>Setting &amp; Participants</h3><p>Patients who started continuous ambulatory peritoneal dialysis at our center between 2006 and 2020 were included and followed up until January 31, 2023.</p></div><div><h3>Exposure</h3><p>Age, sex, diabetes, temporary hemodialysis, angiotensin-converting enzyme inhibitors (ACEis) or angiotensin II receptor blockers (ARBs), diuretics, baseline urine volume, serum albumin, daily glucose exposure, peritonitis, and incremental PD.</p></div><div><h3>Outcomes</h3><p>The primary outcome was early anuria, defined as 24-hour urine volume<!--> <!-->≤100<!--> <!-->mL within the first year of PD initiation. Secondary outcomes included all-cause mortality, cardiovascular disease mortality, technique failure, and peritonitis.</p></div><div><h3>Analytical Approach</h3><p>Cox proportional hazards model.</p></div><div><h3>Results</h3><p>A total of 2,592 patients undergoing continuous ambulatory peritoneal dialysis aged 46.7<!--> <!-->±<!--> <!-->14.9 years were recruited. Among them, 58.9% were male, and 24.0% had diabetes. Within the first year of PD therapy, 159 (6.13%) patients developed anuria, with a median duration of 7.53 (interquartile range, 3.93-10.0) months. Higher baseline urine volume (hazard ratio [HR], 0.93; 95% confidence interval [CI], 0.90-0.97), higher serum albumin (HR, 0.92; 95% CI, 0.88-0.95), having diabetes before PD (HR, 0.57; 95% CI, 0.35-0.92), and prescribed incremental PD (HR, 0.27; 95% CI, 0.14-0.51) were associated with a reduced risk for early anuria, whereas a higher level of daily glucose exposure (HR, 1.01; 95% CI, 1.00-1.01) was identified as a risk factor for early anuria. Subgroup analyses showed that using ACEis or ARBs was linked to a lower risk of early anuria (HR, 0.25; 95% CI, 0.09-0.69) in diabetic patients. Treating early anuria as a time-dependent covariate, early anuria was associated with a higher risk for all-cause mortality (HR, 1.69; 95% CI, 1.23-2.32) and technique failure (HR, 1.43; 95% CI, 1.00-2.04) after adjusting for confounding factors.</p></div><div><h3>Limitations</h3><p>Single-center and observational study.</p></div><div><h3>Conclusions</h3><p>Among PD patients at a single center in China, early anuria was relatively uncommon but associated with an increased risk of mortality and PD technique failure. Incremental PD, higher baseline urine output and serum albumin, and lower daily glucose exposure were associated with a lower risk of early anuria. Clinical trials are needed to evaluate the optimal PD techniques to preserve residual kidney function and maximaze outcomes.</p></div><div><h3>Plain-Language Summary</h3><p>The development of anuria has been linked to worse clinical outcomes in patients undergoing peritoneal dialysis (PD). However, does the development of early anuria, which is defined as 24-hour urine volume<!--> <!-->≤100<!--> <!-->mL, within the first year after PD initiation influence the clinical outcomes of these patients? What are the predictors of early anuria? We conducted a single-center retrospective cohort study and found lower baseline urine volume, lower serum albumin, full-dose PD start, absence of diabetes mellitus, higher daily glucose exposure, and in patients with diabetes mellitus, non-use of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers were associated with early anuria. Early anuria was related to a higher risk for all-cause mortality and technique failure. The results provide information for optimizing patient care and improving the prognosis of patients undergoing PD.</p></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590059524000931/pdfft?md5=44ca96080dd7541b3c31776390c58d80&pid=1-s2.0-S2590059524000931-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590059524000931","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale & Objective

The development of anuria has been linked to worse clinical outcomes in patients undergoing peritoneal dialysis (PD). Our objective was to investigate the incidence, risk factors, and associated clinical outcomes of anuria within the first year after starting PD.

Study Design

Retrospective cohort study.

Setting & Participants

Patients who started continuous ambulatory peritoneal dialysis at our center between 2006 and 2020 were included and followed up until January 31, 2023.

Exposure

Age, sex, diabetes, temporary hemodialysis, angiotensin-converting enzyme inhibitors (ACEis) or angiotensin II receptor blockers (ARBs), diuretics, baseline urine volume, serum albumin, daily glucose exposure, peritonitis, and incremental PD.

Outcomes

The primary outcome was early anuria, defined as 24-hour urine volume ≤100 mL within the first year of PD initiation. Secondary outcomes included all-cause mortality, cardiovascular disease mortality, technique failure, and peritonitis.

Analytical Approach

Cox proportional hazards model.

Results

A total of 2,592 patients undergoing continuous ambulatory peritoneal dialysis aged 46.7 ± 14.9 years were recruited. Among them, 58.9% were male, and 24.0% had diabetes. Within the first year of PD therapy, 159 (6.13%) patients developed anuria, with a median duration of 7.53 (interquartile range, 3.93-10.0) months. Higher baseline urine volume (hazard ratio [HR], 0.93; 95% confidence interval [CI], 0.90-0.97), higher serum albumin (HR, 0.92; 95% CI, 0.88-0.95), having diabetes before PD (HR, 0.57; 95% CI, 0.35-0.92), and prescribed incremental PD (HR, 0.27; 95% CI, 0.14-0.51) were associated with a reduced risk for early anuria, whereas a higher level of daily glucose exposure (HR, 1.01; 95% CI, 1.00-1.01) was identified as a risk factor for early anuria. Subgroup analyses showed that using ACEis or ARBs was linked to a lower risk of early anuria (HR, 0.25; 95% CI, 0.09-0.69) in diabetic patients. Treating early anuria as a time-dependent covariate, early anuria was associated with a higher risk for all-cause mortality (HR, 1.69; 95% CI, 1.23-2.32) and technique failure (HR, 1.43; 95% CI, 1.00-2.04) after adjusting for confounding factors.

Limitations

Single-center and observational study.

Conclusions

Among PD patients at a single center in China, early anuria was relatively uncommon but associated with an increased risk of mortality and PD technique failure. Incremental PD, higher baseline urine output and serum albumin, and lower daily glucose exposure were associated with a lower risk of early anuria. Clinical trials are needed to evaluate the optimal PD techniques to preserve residual kidney function and maximaze outcomes.

Plain-Language Summary

The development of anuria has been linked to worse clinical outcomes in patients undergoing peritoneal dialysis (PD). However, does the development of early anuria, which is defined as 24-hour urine volume ≤100 mL, within the first year after PD initiation influence the clinical outcomes of these patients? What are the predictors of early anuria? We conducted a single-center retrospective cohort study and found lower baseline urine volume, lower serum albumin, full-dose PD start, absence of diabetes mellitus, higher daily glucose exposure, and in patients with diabetes mellitus, non-use of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers were associated with early anuria. Early anuria was related to a higher risk for all-cause mortality and technique failure. The results provide information for optimizing patient care and improving the prognosis of patients undergoing PD.

腹膜透析患者的早期无尿:发生率、风险因素和相关临床结果
研究理由和目的腹膜透析(PD)患者出现无尿与临床预后恶化有关。我们的目的是调查腹膜透析开始后第一年内无尿症的发生率、风险因素和相关临床结局。暴露年龄、性别、糖尿病、临时血液透析、血管紧张素转换酶抑制剂(ACEis)或血管紧张素II受体阻滞剂(ARBs)、利尿剂、基线尿量、血清白蛋白、每日葡萄糖暴露量、腹膜炎和增量腹膜透析。结果主要结果是早期无尿,定义为开始腹膜透析后第一年内24小时尿量≤100 mL。次要结果包括全因死亡率、心血管疾病死亡率、技术衰竭和腹膜炎。结果共招募了 2592 名接受持续非卧床腹膜透析的患者,年龄为(46.7 ± 14.9)岁。其中,58.9%为男性,24.0%患有糖尿病。在接受腹膜透析治疗的第一年内,159 名(6.13%)患者出现无尿症状,中位持续时间为 7.53 个月(四分位间范围为 3.93-10.0 个月)。基线尿量较高(危险比 [HR],0.93;95% 置信区间 [CI],0.90-0.97)、血清白蛋白较高(HR,0.92;95% CI,0.88-0.95)、PD 前患有糖尿病(HR,0.57;95% CI,0.35-0.92)、处方增量 PD(HR,0.27;95% CI,0.14-0.51)与早期无尿风险降低相关,而较高水平的每日葡萄糖暴露(HR,1.01;95% CI,1.00-1.01)被确定为早期无尿的风险因素。亚组分析表明,使用 ACEis 或 ARBs 与糖尿病患者早期无尿的风险降低有关(HR,0.25;95% CI,0.09-0.69)。将早期无尿作为时间依赖性协变量处理,在调整混杂因素后,早期无尿与较高的全因死亡风险(HR,1.69;95% CI,1.23-2.32)和技术失败风险(HR,1.43;95% CI,1.00-2.04)相关。增量腹膜透析、较高的基线尿量和血清白蛋白以及较低的每日葡萄糖暴露与较低的早期无尿风险相关。需要进行临床试验来评估最佳腹膜透析技术,以保留残余肾功能和最大化透析效果。然而,在开始腹膜透析后的第一年内出现早期无尿(定义为 24 小时尿量≤100 毫升)是否会影响这些患者的临床预后?早期无尿的预测因素是什么?我们进行了一项单中心回顾性队列研究,发现较低的基线尿量、较低的血清白蛋白、全剂量起始 PD、无糖尿病、较高的每日葡萄糖暴露量,以及糖尿病患者未使用血管紧张素转换酶抑制剂/血管紧张素 II 受体阻滞剂与早期无尿有关。早期无尿与全因死亡和技术衰竭的风险较高有关。研究结果为优化患者护理和改善腹腔镜手术患者的预后提供了信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信